ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody [clone 4I7] (RQ6748)

ACSL4 Antibody Human Rectal Adenocarcinoma IHC. Immunohistochemical staining of FFPE moderately differentiated human rectal adenocarcinoma tissue using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH8 EDTA buffer. The tissue was stained with an HRP-conjugated secondary antibody and DAB chromogen. Strong cytoplasmic staining is observed throughout the neoplastic glandular epithelium, while the surrounding stromal tissue exhibits comparatively weak immunoreactivity. The staining pattern is consistent with the metabolic role of ACSL4 in lipid processing and membrane remodeling within epithelial tumor cells. This ACSL4 Antibody is well suited for investigating long chain fatty acid activation, lipid metabolism, ferroptosis, and colorectal cancer biology in human tissue sections.

ACSL4 Antibody Human Renal Pelvis Squamous Metaplasia IHC. Immunohistochemical staining of FFPE human renal pelvis tissue with squamous metaplasia using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH8 EDTA buffer. The tissue was stained with an HRP-conjugated secondary antibody and DAB chromogen. Moderate cytoplasmic staining is observed within the metaplastic squamous epithelium, with additional immunoreactivity present in adjacent epithelial cells, consistent with the expression of ACSL4 in metabolically active tissues. This ACSL4 Antibody is suitable for investigating long chain fatty acid activation, lipid metabolism, ferroptosis, and epithelial remodeling in human tissue sections.

ACSL4 Antibody Human Ovarian Cancer IHC. Immunohistochemical staining of FFPE human ovarian cancer tissue using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH8 EDTA buffer. The tissue was stained with an HRP-conjugated secondary antibody and DAB chromogen. Diffuse moderate to strong cytoplasmic staining is observed throughout the neoplastic cells, while the surrounding stromal tissue exhibits comparatively weaker immunoreactivity. This expression pattern is consistent with the established role of ACSL4 in lipid metabolism and membrane phospholipid remodeling in tumor cells. This ACSL4 Antibody is well suited for investigating long chain fatty acid activation, ferroptosis, and metabolic reprogramming in ovarian cancer research.

ACSL4 Antibody Human Bladder Carcinoma IHC. Immunohistochemical staining of FFPE human bladder epithelial carcinoma tissue using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH8 EDTA buffer. The tissue was stained with an HRP-conjugated secondary antibody and DAB chromogen. Moderate to strong cytoplasmic staining is observed throughout the neoplastic urothelial cells, while the surrounding stromal tissue shows comparatively weaker immunoreactivity. This staining pattern is consistent with the role of ACSL4 in lipid metabolism, membrane remodeling, and the altered metabolic state of malignant epithelial cells. This ACSL4 Antibody is well suited for investigating long chain fatty acid activation, ferroptosis, and metabolic reprogramming in bladder cancer research.

ACSL4 Antibody Human Lung Cancer IHC. Immunohistochemical staining of FFPE human lung cancer tissue using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH8 EDTA buffer. The tissue was stained with an HRP-conjugated secondary antibody and DAB chromogen. Moderate cytoplasmic staining is observed in scattered neoplastic cells, while adjacent stromal components exhibit comparatively weak immunoreactivity. This staining pattern is consistent with the heterogeneous expression of ACSL4 reported in lung tumors and reflects its role in lipid metabolism and membrane phospholipid remodeling. This ACSL4 Antibody is suitable for investigating long chain fatty acid activation, ferroptosis, and metabolic reprogramming in lung cancer research.

ACSL4 Antibody Human Cancer Cell WB. Western blot analysis of human HepG2 (lane 1), PC-3 (lane 2), HeLa (lane 3), and Caco-2 (lane 4) cell lysates using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody. A predominant band is detected at approximately 74-80 kDa in all four cell lines, corresponding to the expected molecular weights of the short and long ACSL4 isoforms. The consistent detection across multiple human cancer-derived cell lines supports reliable recognition of endogenous ACSL4. This ACSL4 Antibody is well suited for Western blot analysis of long chain fatty acid activation, lipid metabolism, ferroptosis, and cellular metabolic regulation.

ACSL4 Antibody Human Cervical Cancer Cell IF. Immunofluorescent staining of FFPE human SiHa cells using ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody following heat-induced epitope retrieval in pH6 citrate buffer. ACSL4 was detected with a green fluorescent secondary antibody, while nuclei were counterstained with DAPI (blue). The staining demonstrates predominantly cytoplasmic localization with a diffuse distribution throughout the cell body, consistent with the association of ACSL4 with intracellular membrane systems involved in lipid metabolism. This ACSL4 Antibody is well suited for immunofluorescent analysis of long chain fatty acid activation, ferroptosis, and lipid metabolic pathways in human cells.

ACSL4 Antibody Human Liver Cancer Cell FACS. Flow cytometric analysis of human HepG2 cells stained with ACSL4 Antibody / Long Chain Fatty Acid Activation Enzyme Antibody at 1 ug/10^6 cells following blocking with goat sera. Red represents unstained cells, green the isotype control, and blue the ACSL4 antibody. The clear rightward shift of the ACSL4 antibody population relative to both controls demonstrates specific detection of ACSL4 expression in HepG2 cells. This ACSL4 Antibody is well suited for flow cytometric analysis of long chain fatty acid activation, ferroptosis, lipid metabolism, and metabolic regulation in human cells.